Inhibition of Chk1 kills tetraploid tumor cells through a p53-dependent pathway
about
Dissecting the genomic complexity underlying medulloblastomaCaloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagyTrial Watch: Targeting ATM-CHK2 and ATR-CHK1 pathways for anticancer therapySystems biology of cisplatin resistance: past, present and futureTwo 4N cell-cycle arrests contribute to cisplatin-resistanceUpregulation of Nox4 in the aging vasculature and its association with smooth muscle cell polyploidyMultipolar mitosis of tetraploid cells: inhibition by p53 and dependency on Mos.An automated fluorescence videomicroscopy assay for the detection of mitotic catastropheTransgenerational cell fate profiling: a method for the graphical presentation of complex cell cycle alterationsResveratrol and aspirin eliminate tetraploid cells for anticancer chemoprevention.p21-Activated kinase 5 affects cisplatin-induced apoptosis and proliferation in hepatocellular carcinoma cells.p53: guardian of ploidyIllicit survival of cancer cells during polyploidization and depolyploidization.Cell death signaling and anticancer therapySelective killing of p53-deficient cancer cells by SP600125.Whole-genome duplication increases tumor cell sensitivity to MPS1 inhibition.EGFR inhibitors exacerbate differentiation and cell cycle arrest induced by retinoic acid and vitamin D3 in acute myeloid leukemia cellsMedulloblastomics: the end of the beginning.Size Does Matter: Why Polyploid Tumor Cells are Critical Drug Targets in the War on Cancer.Abnormal mitosis triggers p53-dependent cell cycle arrest in human tetraploid cells.Antineoplastic activity of ouabain and pyrithione zinc in acute myeloid leukemia.Synergistic proapoptotic effects of the two tyrosine kinase inhibitors pazopanib and lapatinib on multiple carcinoma cell lines.Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes.Reversible regulation of ORC2 SUMOylation by PIAS4 and SENP2.RNA-sequencing dissects the transcriptome of polyploid cancer cells that are resistant to combined treatments of cisplatin with paclitaxel and docetaxel.Hyperdiploid tumor cells increase phenotypic heterogeneity within Glioblastoma tumors.Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018.Losmapimod Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer by Preventing Tetraploidization.Losmapimod: A Novel Clinical Drug to Overcome Gefitinib-Resistance.Caspase 2 in mitotic catastrophe: The terminator of aneuploid and tetraploid cells.Preferential killing of p53-deficient cancer cells by reversine.
P2860
Q24621907-2EC950F3-0CE2-4F21-856B-3D0E654D08A9Q24631354-CB90C300-3BB9-45CA-AE6C-5F3C37AE9284Q26745686-A057BEB9-EB14-4843-A89B-C9E06A2A3B35Q26863585-F1B426DB-3D91-4BEB-A3AC-8D4D2077AB0AQ28485896-DC2CCB67-3E90-4326-9363-8D343C64F6B6Q28576215-A8E5BDBF-C48F-410C-A9D3-F30F3161DC2CQ30494172-276E0F13-1049-4DD5-A095-5A3F0D1B4ED3Q30498067-E505EFBC-2370-48E6-A086-A5EBB0942E3BQ30535409-695F7095-AC4A-48A0-A180-F636A6F95D35Q30573152-A8110D76-762C-4FDA-AEF7-1D8A6CDCB39BQ34456644-2F703D3A-F349-4040-864E-9189902DA0C6Q35190108-4ED5EB68-61DC-4443-BC7B-38B8AE641D6CQ35227425-4AE21783-DAF2-43C5-9AD9-B35FFDDE4504Q35972102-F8BB0A6B-21EB-4799-AD4B-DD2C49DF9C42Q36238666-80CB8CF4-B559-4B6C-B97C-D9DF5D2A6B13Q36729558-7753E127-5ACF-47BA-9113-AB47747F26CCQ37420045-F51AE623-01C4-418C-AA09-B3770601F331Q37469904-AC54610A-2D6C-42E5-B096-F2A1B171EF18Q38218129-F38E96E4-7B4B-4591-BC3A-A47AAB8F18E1Q39159318-2B437560-DE65-4D66-B34C-BCF51A91BCEAQ39439229-0C081B5B-31D8-4DD1-A510-28CAA28A0E4EQ39800101-623E81FE-2670-49E5-98E6-2FE866F9C33EQ41764481-BFE1F006-9CA0-4017-BD6F-8B325C20D94BQ42378412-6C51B08F-8ADD-4C03-840E-68C3FCD1BD34Q42777412-D91B2F6A-E1EF-41DC-B576-E7A3507644A9Q46581912-235A5C0A-E5EE-4891-9E1A-7EF0877D2F20Q47843948-AB5A69DE-E9AE-43EA-AFE0-017D1E3326BDQ49340076-9EF57C14-CA95-4304-82BB-5E7FB71206F9Q49359622-1D400284-6EA6-4BD7-8988-F8AC368A59D7Q52765570-39F16B14-C462-4D01-B83C-D23BD7629679Q54510509-A4C9C8FA-F8A0-410F-B7F3-29C7FDA996E9
P2860
Inhibition of Chk1 kills tetraploid tumor cells through a p53-dependent pathway
description
2007 nî lūn-bûn
@nan
2007 թուականին հրատարակուած գիտական յօդուած
@hyw
2007 թվականին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Inhibition of Chk1 kills tetraploid tumor cells through a p53-dependent pathway
@ast
Inhibition of Chk1 kills tetraploid tumor cells through a p53-dependent pathway
@en
Inhibition of Chk1 kills tetraploid tumor cells through a p53-dependent pathway
@nl
type
label
Inhibition of Chk1 kills tetraploid tumor cells through a p53-dependent pathway
@ast
Inhibition of Chk1 kills tetraploid tumor cells through a p53-dependent pathway
@en
Inhibition of Chk1 kills tetraploid tumor cells through a p53-dependent pathway
@nl
prefLabel
Inhibition of Chk1 kills tetraploid tumor cells through a p53-dependent pathway
@ast
Inhibition of Chk1 kills tetraploid tumor cells through a p53-dependent pathway
@en
Inhibition of Chk1 kills tetraploid tumor cells through a p53-dependent pathway
@nl
P2093
P2860
P50
P1433
P1476
Inhibition of Chk1 kills tetraploid tumor cells through a p53-dependent pathway
@en
P2093
Ken A Olaussen
Lisa Nanty
Maria Castedo
Michelle Prudhomme
Philippe Dessen
Roy M Golsteyn
Sonia Vivet
Vladimir Lazar
P2860
P356
10.1371/JOURNAL.PONE.0001337
P407
P577
2007-01-01T00:00:00Z